A delayed hypersensitivity to 7,12-dimethylbenz(a)anthracene was elicited in guinea pigs after contact sensitization. This sensitivity was characterized by its time of appearance, histology, specificity, and transfer characteristics. The reaction had its maximal dermal reactivity 24 hr after challenge, was characterized by a mononuclear cell infiltration, demonstrated immunological specificity, and could be transferred with leukocytes to normal animals.
A delayed hypersensitivity to 7,12-dimethylbenz(a)anthracene was elicited in guinea pigs after contact sensitization. This sensitivity was characterized by its time of appearance, histology, specificity, and transfer characteristics. The reaction had its maximal dermal reactivity 24 hr after challenge, was characterized by a mononuclear cell infiltration, demonstrated immunological specificity, and could be transferred with leukocytes to normal animals.
Chemically induced tumors have been reported in guinea pigs (2, 5) , although this species appears to be more resistant to chemical carcinogenesis than mice or rats. Soluble antigens of chemically induced tumors in inbred guinea pigs have been shown to elicit delayed hypersensitivity and to induce transplantation immunity (6) . Inhibition of macrophage migration can be employed to measure delayed hypersensitivity to soluble antigens of chemically induced tumors in guinea pigs (1) .
In Guinea pigs of the Hartley strain weighing 400 to 600 g were sensitized by an application of a 2% solution of DMBA in acetone on a 5-cm2 clipped area of the neck each day for 7 days. Details for producing contact sensitization have been described (4) . Five days after the last painting, the animals were skintested with 1, 0.5, and 0.1% DMBA and 1% solutions of BP, BA, and MC in olive oil. The reactions were read at 24 and 48 hr according to the following schedule: 0, patchy erythema; 2, homogeneous erythema; 3, homogeneous erythema and induration; 4, erythema, induration, and raised reaction site. For passive transfer experiments, 15 ml of sterile, light mineral oil was injected intra-abdominally. Forty-eight hours later, the animals were exanguinated and the peritoneal exudative cells were collected in three washes of the abdominal cavity with Hank's balanced salt solution (HBSS). The washings were pooled and immediately centrifuged at 500 X g for 15 min. Suprascapular lymph nodes were dissected from the donors, pooled, and minced, and the cells were expressed through a stainless-steel screen and centrifuged.
The peritoneal exudative cells and lymph node cells were resuspended in HBSS, counted, and immediately injected intra-abdominally into separate recipient animals. Recipients were skin-tested with all of the skin test reagents 48 hr later.
RESULTS
Four groups of 13 to 15 animals each were skin-tested with 1, 0.5, and 0.1% DMBA in olive oil after topical sensitization to that agent. No reactions were observed immediately or 6 hr A DMBA SENSITIVITY IN GUINEA PIGS after testing. Without exception, however, reactions typified by homogeneous erythema and induration were observed at the skin test sites to 1% DMBA 24 and 48 hr after testing. Weaker reactions were recorded to challenges with 0.5 and 0.1% of the chemical ( Table 1 ). The specificity of these dermal reactions was determined by skin-testing the same animals with hydrocarbons having similar structures to that of DMBA. Cross-reactions were observed to BP, occasionally to BA, but not to MC ( Table 1) . The ability of these test reagents to elicit a dermal response was assured by inducing and eliciting sensitivities to each of these chemicals in other animals. Untreated control animals did not respond to any of the agents employed.
Histological examination of the skin test sites and of lymph nodes draining the treatment area confirmed the skin test results. Cell infiltration at the skin test site at 24 and 48 hr was predominately mononuclear. Suprascapular lymph nodes draining the treatment site showed increased numbers of immunoblasts, stained with methyl green pyronine, and extensive development in the paracortical regions 5 days after treatment.
The passive transfer characteristics of this sensitivity was tested with peritoneal exudative cells, lymph node cells, and serum from sensitive animals ( Table 2) . Peritoneal exudative cells passively transferred this sensitivity when at least 109 cells were employed. Only 1 of 11 transfers with less than 109 cells was positive. Lymph node cells were effective when 0.3 X 10' cells were employed in six experiments, although passive sensitization was achieved once with less than 0.3 X 109 lymph node cells. Volumes from 10 to 55 ml of serum were tested in seven passive transfer experiments. Passive sensitization with serum could not be demonstrated. It was also noted that the recipients which were passively sensitized to DMBA developed cross-reactions to BP but not to BA or MC ( VOL. 3, 1971 the changes that occur in the inductive phase of delayed hypersensitivities.
We have characterized a DMBA sensitivity in guinea pigs by applying established criteria for delayed hypersensitivity. This sensitivity is characterized by a dermal reactivity maximal 24 to 48 hr after testing, resulting in mononuclear cell infiltration of the skin test site. The inductive period of this sensitivity closely resembled the inductive phase of delayed hypersensitivity responses to other contact sensitizing agents. Large numbers of immunoblasts were found in lymph nodes draining skin treatment sites. This agrees with previous findings (3) that certain carcinogens and known sensitizing agents initiate similar cellular events in mice and guinea pigs.
The transfer characteristics of the DMBA response established the cellular basis for this sensitivity. Previous descriptions of DMBA sensitivity were suggestive of delayed hypersensitivity, but this could not be established without the transfer experiments. Lymphoid cells from both peritoneal exudates and lymph nodes passively transferred DMBA reactivity, whereas repeated attempts with large volumes of serum from sensitive animals did not. The number of exudative cells or lymph node cells needed to accomplish passive transfer was consistent with the number of cells necessary to transfer dinitrofluorobenzene sensitivity (4) . The specificity of the DMBA sensitivity was similar to that previously described (3) and could be demonstrated in both actively and passively sensitized animals.
Sensitized animals did not develop tumors during a 1-year observation period. This was not surprising since carcinogen-induced guinea pig tumors are not easily produced after this kind of exposure. Since the guinea pig demonstrates a resistance to the carcinogenic effects of DMBA, while developing a delayed hypersensitivity to that agent, this animal system makes a convenient model for investigating the relationships between the initial immunological event, the delayed hypersensitivity to DMBA, and the resistance of the guinea pig to carcinogenesis.
